UK’s drug supply contingency plan for hard BrexitThe UK government has issued several documents to help businesses in planning for the eventuality of a no-deal Share XUK’s drug supply contingency plan for hard Brexithttps://pharmaphorum.com/views-analysis-market-access/hard-brexit-uk-drug-supply-contingency-plan/
Ipsen appoints new general manager for the UK & IrelandThe French pharma company appointed a new general manager for its UK and Ireland office, Asad Mohsin Ali, Share XIpsen appoints new general manager for the UK & Irelandhttps://pharmaphorum.com/news/ipsen-appoints-new-general-manager/
Sanofi’s rare disease drug Cablivi approved in the EUThe European Commission has approved Sanofi’s Cablivi, the first treatment for patients with the rare blood-clotting disorder, acquired Share XSanofi’s rare disease drug Cablivi approved in the EUhttps://pharmaphorum.com/news/sanofi-cablivi-approved-europe/
AstraZeneca improves diabetes pen to maintain its market shareThe European Commission (EC) has approved AstraZeneca’s Bydureon BCise, a new weekly formulation of established GLP-1 diabetes drug Share XAstraZeneca improves diabetes pen to maintain its market sharehttps://pharmaphorum.com/news/astrazeneca-improves-diabetes-pen-to-maintain-its-market-share/
England reveals plans allowing abortion pill to be taken at homeWomen in England will be able to take an early abortion pill in the safety of their own Share XEngland reveals plans allowing abortion pill to be taken at homehttps://pharmaphorum.com/news/england-reveals-plans-allowing-abortion-pill-to-be-taken-at-home/
AstraZeneca changes contractors as HQ delayed againAstraZeneca has switched building contractors in a bid to hasten progress on its delayed and over-budget new headquarters, Share XAstraZeneca changes contractors as HQ delayed againhttps://pharmaphorum.com/news/astrazeneca-changes-contractors-as-hq-delayed-again/
Brexit from the inside: MP’s views on how it will impact pharmaWith the potential for a hard-no-deal Brexit becoming closer to reality with each passing day, the question of Share XBrexit from the inside: MP’s views on how it will impact pharmahttps://pharmaphorum.com/views-and-analysis/brexit-inside-mps-views-impact-pharma/
Boehringer joins UK academics in battle against cystic fibrosisBoehringer Ingelheim (BI) and the UK Cystic Fibrosis Gene Therapy Consortium announced a global collaboration to develop a Share XBoehringer joins UK academics in battle against cystic fibrosishttps://pharmaphorum.com/news/boehringer-battles-against-cystic-fibrosis/
NHS faces legal action over fertility treatment for gender transitioning patientsEngland’s NHS must offer transgender patients awaiting transitioning treatment access to fertility services, or face legal action according Share XNHS faces legal action over fertility treatment for gender transitioning patientshttps://pharmaphorum.com/news/nhs-fertility-treatment-gender-transitioning-patients/
